According to the latest report from Meticulous Research®, the Neuromodulation Systems Market is set to experience significant growth, with projections indicating it will reach $10.29 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.2% over the forecast period. This substantial growth is primarily driven by the rising prevalence of neurological disorders and nerve injuries, continuous advancements in neuromodulation and neurostimulation technologies, and expanding clinical applications. Clinical trials, in particular, have been a driving force in validating new uses for neuromodulation systems, fostering more widespread adoption and innovation in the field.